EAN 2023 | Current treatment options for RBD

Ambra Stefani, MD, PhD, University of Innsbruck, Innsbruck, Austria, addresses the limited treatment options for REM sleep behavior disorder (RBD), with no distinction between isolated and secondary forms. Current options include clonazepam and melatonin. Sodium oxybate has also been studied, though recent trial results did not show significant efficacy versus placebo. These treatments focus on symptom management, as there is currently no medication for disease modification. Ongoing research offers hope for future treatments in the coming years for patients with RBD. This interview took place at the European Academy of Neurology (EAN) 2023 Congress in Budapest, Hungary.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.